Skip to main content
International
Ask us anything:
  • About
        • About We challenge convention so healthy can be possible
        • Our Story
          • Amneal at-a-glance
          • Our Founders
          • Our Milestones
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Leadership
          • Executive Leadership
          • Board of Directors
        • Our Locations
        • Responsibility
          • The Amneal Patient Assistance Programs
          • Product Donations
          • National & Local Philanthropy
          • Compliance and Ethics
        • Patient Community Connections
          • Our Commitment to Parkinson's
        • Awards & Recognition
  • Products
        • Products We create essential medicines
        • Our Portfolio
          • Biosciences
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
  • Research & Development
        • Research & Development We invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
  • Investors
        • Investors Become an Informed Investor
  • News
  • Careers
        • Careers Help make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
  • Contact
  • Customer Login
Amneal Pharmaceuticals
  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds

Home Home  >  News  >  Press Releases

  • Investor Relations
  • Financial Reports
    • SEC Filings
    • Annual Reports
    • Quarterly & Other Reports
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Policies
    • Executive Officers & Directors
    • Board Committees
  • Investor Resources
    • Analysts
    • Investor FAQ
    • Email Alerts
    • Information Request
    • RSS Feeds
Normal
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
Dec 22, 2016
Impax Launches Generic Version of Kadian® (morphine sulfate) Extended Release Capsules, USP CII
Dec 20, 2016
Impax Laboratories Announces Leadership Transition
Nov 28, 2016
Impax Announces Appointment of J. Kevin Buchi to Board of Directors
Nov 22, 2016
Impax to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 16, 2016
Liberty Science Center Appoints New Managing And Advisory Trustees To Board
PDF format download (opens in new window)
Nov 09, 2016
Impax Reports Third Quarter 2016 Financial Results
PDF format download (opens in new window)
Oct 31, 2016
Media Alert: Experts Available Now And At American College of Allergy, Asthma and Immunology (ACAAI) Scientific Meeting
PDF format download (opens in new window)
Oct 24, 2016
Amneal Biosciences Introduces Second Institutional Product
PDF format download (opens in new window)
Oct 18, 2016
Amneal Launches First Vagifem® Generic
PDF format download (opens in new window)
Oct 06, 2016
Amneal Biosciences Launches First Product
PDF format download (opens in new window)
Oct 04, 2016
Amneal wins Company of the Year, Americas at the Global Generics & Biosimilars Awards 2016
PDF format download (opens in new window)
Oct 04, 2016
Impax to Report Third Quarter 2016 Results on November 9, 2016
PDF format download (opens in new window)
Sep 22, 2016
Impax Launches Generic Version of Metadate CD® (Methylphenidate Hydrochloride Extended-Release Capsules)
PDF format download (opens in new window)
Sep 07, 2016
Impax to Present at the Morgan Stanley Global Healthcare Conference
PDF format download (opens in new window)
Aug 30, 2016
Impax Provides Update on Epinephrine Injection, USP Auto-Injector
PDF format download (opens in new window)
Aug 26, 2016
Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg Due to the Potential for 100 mg Blister Cards being Packaged in 200 mg Containers
Aug 22, 2016
Richard A. Bierly Appointed to Impax Laboratories Board of Directors
PDF format download (opens in new window)
Aug 09, 2016
Impax Reports Second Quarter 2016 Financial Results
PDF format download (opens in new window)
Jul 21, 2016
Impax Names Douglas S. Boothe President of Generics Division
PDF format download (opens in new window)
Jul 07, 2016
Impax to Report Second Quarter 2016 Results on August 9, 2016
PDF format download (opens in new window)
Jun 29, 2016
New Generic Equivalent for Lutera® 28
PDF format download (opens in new window)
Jun 21, 2016
Impax Signs Definitive Agreements to Acquire Generic Products
PDF format download (opens in new window)
Jun 16, 2016
Amneal Pharmaceuticals Honored with Best Overall Generics Manufacturer Award by Healthcare Distribution Alliance
PDF format download (opens in new window)
Jun 14, 2016
Amneal Pharmaceuticals Company GmbH and Iconovo AB Execute Development and License Agreement
PDF format download (opens in new window)
Jun 02, 2016
Impax to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
PDF format download (opens in new window)
May 10, 2016
Impax Reports First Quarter 2016 Financial Results
PDF format download (opens in new window)
May 04, 2016
Impax to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
PDF format download (opens in new window)
Apr 18, 2016
Impax to Report First Quarter 2016 Results on May 10, 2016
PDF format download (opens in new window)
Apr 14, 2016
Impax Announces the Retirement of Nigel Ten Fleming, Ph.D. and Michael Markbreiter from its Board of Directors
PDF format download (opens in new window)
Apr 13, 2016
Impax Announces Availability of EMVERM™ (mebendazole) Chewable Tablets, 100 mg
PDF format download (opens in new window)
Mar 24, 2016
Amneal Announces the Launch of Diclofenac Sodium Topical Gel 1%
PDF format download (opens in new window)
Mar 11, 2016
Impax to Present at the Barclays Global Healthcare Conference
PDF format download (opens in new window)
Mar 01, 2016
Impax to Present at the 37th Annual Raymond James Institutional Investors Conference
PDF format download (opens in new window)
Feb 22, 2016
Impax Reports Fourth Quarter and Full Year 2015 Financial Results
PDF format download (opens in new window)
Feb 17, 2016
Impax Receives FDA Approval for Generic Version of Adderall XR® (mixed salts of a single-entity amphetamine product) Capsules, CII
PDF format download (opens in new window)
Feb 10, 2016
Chirag and Chintu Patel featured in the OECD Observer
PDF format download (opens in new window)
Feb 02, 2016
Impax Receives Tentative FDA Approval for Generic Version of Vytorin® (ezetimibe and simvastatin) Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg
PDF format download (opens in new window)
Jan 21, 2016
Impax to Report Fourth Quarter and Full Year 2015 Results on February 22, 2016
PDF format download (opens in new window)
Jan 15, 2016
Impax Receives Approval of EMVERM™ (mebendazole) Chewable Tablets, 100 mg
PDF format download (opens in new window)
Jan 05, 2016
Amneal Pharmaceuticals to Present at 34th Annual J.P. Morgan Healthcare Conference
PDF format download (opens in new window)
Jan 05, 2016
Impax to Present at the 34th Annual J.P. Morgan Healthcare Conference
PDF format download (opens in new window)

Investor Faq

Get answers to important investor relation questions.

More

Investor Tools

  • Email Alerts
  • RSS Feeds
  • Email Page

IR Contact

Get answers to your investor relation questions.

More
  • Privacy Policy
  • Copyright & Legal Disclaimer
  • Web Accessibility
© Amneal Pharmaceuticals LLC.
All rights reserved.
Powered By Q4 Inc. 5.86.0.1 (opens in new window)
Back to top